Organogenesis Holdings Inc. (ORGO)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Total revenue | 101,005 | 86,693 | 115,177 | |
| Selling, general and administrative | 73,810 | 72,509 | 71,795 | |
| Research and development | 10,395 | 10,640 | 10,344 | |
| Cost of goods sold | 27,630 | - | - | |
| Write-down to fair value for asset held for sale | 1,746 | 6,567 | - | |
| Total operating expenses | 113,581 | 89,716 | 82,139 | |
| Cost of goods sold | - | 23,723 | 26,796 | |
| Gross profit | - | 62,970 | 88,381 | |
| Loss from operations | -12,576 | -26,746 | 6,242 | |
| Other income (expense), net | 73 | 2 | 52 | |
| Interest income (expense), net | -669 | -961 | 471 | |
| Total other income (expense), net | 742 | 963 | -419 | |
| Net loss before income taxes | -11,834 | -25,783 | 5,823 | |
| Income tax benefit (expense) | -2,442 | -6,940 | -6,508 | |
| Net loss and comprehensive loss | -9,392 | -18,843 | 12,331 | |
| Cumulative dividend on redeemable convertible preferred stock | 2,681 | 2,627 | - | |
| Accretion of redeemable convertible preferred stock to redemption value | 129 | 121 | - | |
| Net loss attributable to common stockholders, basic, total | -12,202 | -21,591 | 12,331 | |
| Basic | 126,853,536 | 126,295,642 | 132,575,301 | |
| Earnings per share-basic | -0.1 | -0.17 | 0.09 | |
| Earnings per share-diluted | -0.1 | -0.17 | 0.09 | |
| Weighted-average common shares outstandingdiluted | 126,853,536 | 126,295,642 | 133,926,755 | |